{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T09:10:49Z","timestamp":1780650649371,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002704","name":"Fundacion Cientifica de la Asociacion Espanola Contra el Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014180","name":"Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["SA113P23"],"award-info":[{"award-number":["SA113P23"]}],"id":[{"id":"10.13039\/501100014180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014180","name":"Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["GRS 2322\/A\/21"],"award-info":[{"award-number":["GRS 2322\/A\/21"]}],"id":[{"id":"10.13039\/501100014180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PI23\/00 681"],"award-info":[{"award-number":["PI23\/00 681"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.aohep.2025.102179","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T16:40:00Z","timestamp":1766594400000},"page":"102179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A three-gene resistome signature as a prognostic tool in hepatocellular carcinoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Anabel","family":"Sanchez-Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4748-0326","authenticated-orcid":false,"given":"Rocio I.R.","family":"Macias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mu\u00f1oz-Bellv\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Forner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Reig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1186-6849","authenticated-orcid":false,"given":"Jose J.G.","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Briz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.aohep.2025.102179_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.aohep.2025.102179_bib0002","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide","volume":"156","author":"Filho","year":"2025","journal-title":"Int J Cancer"},{"issue":"Suppl 4","key":"10.1016\/j.aohep.2025.102179_bib0003","doi-asserted-by":"crossref","first-page":"iv238","DOI":"10.1093\/annonc\/mdy308","article-title":"Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Vogel","year":"2018","journal-title":"Ann oncol: off j Eur Soc Med Oncol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102179_bib0004","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102179_bib0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jhep.2023.11.030","article-title":"Battle of the biopsies: role of tissue and liquid biopsy in hepatocellular carcinoma","volume":"80","author":"Lehrich","year":"2024","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102179_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101567","article-title":"The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO\/World Congress on Gastrointestinal Cancer, Barcelona, 2022","volume":"8","author":"Ducreux","year":"2023","journal-title":"ESMO open"},{"issue":"2","key":"10.1016\/j.aohep.2025.102179_bib0007","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/bjc.2014.199","article-title":"Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma","volume":"111","author":"Golfieri","year":"2014","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.aohep.2025.102179_bib0008","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamaoncol.2023.2677","article-title":"Critical appraisal of guideline recommendations on systemic therapies for advanced hepatocellular carcinoma: A review","volume":"10","author":"Cappuyns","year":"2024","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.aohep.2025.102179_bib0009","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ueg2.12510","article-title":"Systemic therapies in hepatocellular carcinoma: A revolution?","volume":"12","author":"Fortuny","year":"2024","journal-title":"United Eur Gastroenterol J"},{"issue":"11","key":"10.1016\/j.aohep.2025.102179_bib0010","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.3390\/curroncol30110711","article-title":"Advances in immunotherapy for hepatocellular carcinoma (HCC)","volume":"30","author":"Bicer","year":"2023","journal-title":"Curr Oncol"},{"issue":"6","key":"10.1016\/j.aohep.2025.102179_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061663","article-title":"Molecular bases of drug resistance in hepatocellular carcinoma","volume":"12","author":"Marin","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.aohep.2025.102179_bib0012","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0041-1735631","article-title":"Mechanisms of pharmacoresistance in hepatocellular carcinoma: new drugs but old problems","volume":"42","author":"Marin","year":"2022","journal-title":"Semin Liver Dis"},{"issue":"8","key":"10.1016\/j.aohep.2025.102179_bib0013","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2174\/092986710790514462","article-title":"Molecular bases of liver cancer refractoriness to pharmacological treatment","volume":"17","author":"Marin","year":"2010","journal-title":"Curr Med Chem"},{"issue":"2","key":"10.1016\/j.aohep.2025.102179_bib0014","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11596-007-0217-8","article-title":"The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance","volume":"27","author":"Li","year":"2007","journal-title":"J Huazhong Univ Sci Technol Med sci = Hua zhong ke ji xue xue bao Yi xue Ying wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban"},{"issue":"2","key":"10.1016\/j.aohep.2025.102179_bib0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/mol.115.101360","article-title":"A gene expression signature associated with overall survival in patients with hepatocellular carcinoma suggests a new treatment strategy","volume":"89","author":"Gillet","year":"2016","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102179_bib0016","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/pharmaceutics2030300","article-title":"Expression of drug-resistant factor genes in hepatocellular carcinoma patients undergoing chemotherapy with platinum complex by arterial infusion","volume":"2","author":"Sakurada","year":"2010","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.aohep.2025.102179_bib0017","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1021\/mp300028a","article-title":"No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors","volume":"9","author":"Martinez-Becerra","year":"2012","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.aohep.2025.102179_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12020149","article-title":"Precision medicine for hepatocellular carcinoma: clinical perspective","volume":"12","author":"Galun","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.aohep.2025.102179_bib0019","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2147\/JHC.S417123","article-title":"Establishment and clinical application of the nomogram related to risk or prognosis of hepatocellular carcinoma: A review","volume":"10","author":"Wang","year":"2023","journal-title":"J hepatocell carcinoma"},{"issue":"3","key":"10.1016\/j.aohep.2025.102179_bib0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.aohep.2025.102179_bib0021","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.semcancer.2021.02.015","article-title":"Cellular heterogeneity and plasticity in liver cancer","volume":"82","author":"Chan","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102179_bib0022","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.soc.2023.06.010","article-title":"Overview of current hepatocellular carcinoma staging systems: is there an optimal system?","volume":"33","author":"Chavez-Villa","year":"2024","journal-title":"Surg Oncol Clin N Am"},{"issue":"1","key":"10.1016\/j.aohep.2025.102179_bib0023","doi-asserted-by":"crossref","first-page":"e3913","DOI":"10.1002\/cbf.3913","article-title":"Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC)","volume":"42","author":"Pourbagheri-Sigaroodi","year":"2024","journal-title":"Cell Biochem Funct"},{"issue":"5","key":"10.1016\/j.aohep.2025.102179_bib0024","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.aohep.2025.102179_bib0025","article-title":"Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors","volume":"5","author":"Gyorffy","year":"2024","journal-title":"Innov (Camb)"},{"issue":"4","key":"10.1016\/j.aohep.2025.102179_bib0026","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.gpb.2018.07.003","article-title":"HCCDB: A database of hepatocellular carcinoma expression atlas","volume":"16","author":"Lian","year":"2018","journal-title":"Genom Proteom Bioinform"},{"key":"10.1016\/j.aohep.2025.102179_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115209","article-title":"Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells","volume":"165","author":"Sanchez-Martin","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"17","key":"10.1016\/j.aohep.2025.102179_bib0028","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.7150\/jca.44697","article-title":"CK19-positive hepatocellular carcinoma is a characteristic subtype","volume":"11","author":"Zhuo","year":"2020","journal-title":"J Cancer"},{"issue":"2","key":"10.1016\/j.aohep.2025.102179_bib0029","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2009.10.026","article-title":"EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma","volume":"52","author":"Terris","year":"2010","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.aohep.2025.102179_bib0030","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1136\/gutjnl-2019-318912","article-title":"Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas","volume":"68","author":"Zhang","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2025.102179_bib0031","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/bs.acr.2022.01.007","article-title":"Implications of genetic heterogeneity in hepatocellular cancer","volume":"156","author":"Suresh","year":"2022","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.aohep.2025.102179_bib0032","doi-asserted-by":"crossref","first-page":"52","DOI":"10.21037\/tgh.2019.06.07","article-title":"Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1182 patients in Hong Kong","volume":"4","author":"Chan","year":"2019","journal-title":"Transl gastroenterol hepatol"},{"key":"10.1016\/j.aohep.2025.102179_bib0033","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1477-7819-11-212","article-title":"Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy","volume":"11","author":"Ma","year":"2013","journal-title":"World J Surg Oncol"},{"issue":"6","key":"10.1016\/j.aohep.2025.102179_bib0034","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1124\/dmd.112.048181","article-title":"Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites","volume":"41","author":"Swift","year":"2013","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.aohep.2025.102179_bib0035","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/hep.26425","article-title":"Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib","volume":"58","author":"Herraez","year":"2013","journal-title":"Hepatology"},{"issue":"43","key":"10.1016\/j.aohep.2025.102179_bib0036","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.3748\/wjg.v27.i43.7546","article-title":"Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma","volume":"27","author":"Yu","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102179_bib0037","first-page":"621","article-title":"Survivin deficiency induces apoptosis and cell cycle arrest in HepG2 hepatocellular carcinoma cells","volume":"27","author":"Dai","year":"2012","journal-title":"Oncol Rep"},{"issue":"11","key":"10.1016\/j.aohep.2025.102179_bib0038","first-page":"3883","article-title":"Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma","volume":"31","author":"Hoffmann","year":"2011","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.aohep.2025.102179_bib0039","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/BF03402158","article-title":"Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue, and liver diseases","volume":"8","author":"Bonin","year":"2002","journal-title":"Mol Med"},{"issue":"3","key":"10.1016\/j.aohep.2025.102179_bib0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/092986711794839197","article-title":"Structural and functional properties of human multidrug resistance protein 1 (MRP1\/ABCC1)","volume":"18","author":"He","year":"2011","journal-title":"Curr Med Chem"},{"issue":"4","key":"10.1016\/j.aohep.2025.102179_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/cells11040634","article-title":"Upregulation of USP22 and ABCC1 during Sorafenib treatment of hepatocellular carcinoma contribute to development of resistance","volume":"11","author":"Chang","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.aohep.2025.102179_bib0042","first-page":"93","article-title":"The Eighth edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.aohep.2025.102179_bib0043","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0030-1247131","article-title":"Molecular classification and novel targets in hepatocellular carcinoma: recent advancements","volume":"30","author":"Hoshida","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.aohep.2025.102179_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.642563","article-title":"A novel five-gene signature for prognosis prediction in hepatocellular carcinoma","volume":"11","author":"Su","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102179_bib0045","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1186\/s12864-023-09876-3","article-title":"Exploration and validation of a combined hypoxia and m6A\/m5C\/m1A regulated gene signature for prognosis prediction of liver cancer","volume":"24","author":"Ren","year":"2023","journal-title":"BMC genom"},{"issue":"5","key":"10.1016\/j.aohep.2025.102179_bib0046","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1042\/cs1000499","article-title":"Increased levels of typically fetal bile acid species in patients with hepatocellular carcinoma","volume":"100","author":"El-Mir","year":"2001","journal-title":"Clin Sci (L)"},{"issue":"2","key":"10.1016\/j.aohep.2025.102179_bib0047","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020919","article-title":"Establishment and validation of novel prognostic subtypes in hepatocellular carcinoma based on bile acid metabolism gene signatures using bulk and single-cell RNA-seq data","volume":"25","author":"Qu","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.aohep.2025.102179_bib0048","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2025.102179_bib0049","first-page":"1","article-title":"Genomic tests to guide management of breast cancer in Europe: regulation, reimbursement, adoption, and challenges","author":"Verrill","year":"2025","journal-title":"Future Oncol"},{"key":"10.1016\/j.aohep.2025.102179_bib0050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1471-2164-7-278","article-title":"Converting a breast cancer microarray signature into a high-throughput diagnostic test","volume":"7","author":"Glas","year":"2006","journal-title":"BMC genom"},{"issue":"1","key":"10.1016\/j.aohep.2025.102179_bib0051","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MOU.0000000000000131","article-title":"Diagnostic associations of gene expression signatures in prostate cancer tissue","volume":"25","author":"Nguyen","year":"2015","journal-title":"Curr Opin Urol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125004041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125004041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:49:17Z","timestamp":1780649357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268125004041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1665268125004041"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102179","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A three-gene resistome signature as a prognostic tool in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102179"}}